Lymphocyte-depleted Hodgkin’s lymphoma (LDHL) is a rare subtype of Hodgkin’s lymphoma, a cancer that develops in the lymphatic system. Hodgkin’s lymphoma (HL) is an uncommon cancer of the lymphatic ...
Real-world immune-related adverse events in patients with early triple negative breast cancer who received pembrolizumab. Prevention of sacituzumab govitecan (SG)-related neutropenia and diarrhea in ...
Cervical cancer is among the most common malignancies affecting women worldwide. In 2020 alone, approximately 600,000 women were diagnosed with this disease, and over 314,000 died from it. In 99% of ...
SUPRAME: A phase 3 trial comparing IMA203, an engineered T-cell receptor expressing T cell therapy (TCR-T) vs investigator’s choice in patients with previously treated advanced cutaneous melanoma.
Cancer is the second leading cause of death worldwide. It accounts for an estimated 9.6 million deaths, or 1 in 6 deaths, in 2018, according to the World Health Organization (WHO). The numbers are ...
We recently published 10 Best Biotech Stocks to Buy Under $10. ImmunityBio, Inc. is among them. ImmunityBio, Inc. (NASDAQ:IBRX) is a commercial-stage biotechnology company developing next-generation ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results